Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study investigated the association of chronic inflammatory markers with the clinical outcome after endovascular aneurysm repair (EVAR) for abdominal aortic aneurysm.
The study included 230 consecutive AAA patients, treated electively by EVAR from March 2016 to February 2019. The values of simple inflammatory markers,neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR), were measured pre- and postoperatively.Adverse events included any major adverse cardiovascular events (MACE), acute kidney injury and death from any cause.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| EVAR | Patinets with AAA, treated electively by EVAR. The values of simple inflammatory markers,neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR), were measured pre- and postoperatively. Adverse events included any major adverse cardiovascular events (MACE), acute kidney injury and death from any cause |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| NLR | Other | neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) |
|
| Measure | Description | Time Frame |
|---|---|---|
| NLR major cardiovascular events (MACE) | NLR indicator for major cardiovascular events (MACE) | Day 4 postopertively |
| PLR major cardiovascular events (MACE) | PLR indicator for major cardiovascular events (MACE) | Day 4 postopertively |
| NLR acute kidney injury (AKI) | NLR indicator for acute kidney injury (AKI) | Day 4 postopertively |
| PLR acute kidney injury (AKI) | PLR indicator for acute kidney injury (AKI) | Day 4 postopertively |
| NLR death | NLR indicator for death | Day 4 postopertively |
| PLR death | PLR indicator for death | Day 4 postopertively |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
The study included consecutive AAA patients treated electively by EVAR
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Elena Arnaoutoglou, MD, PhD | University of Thessaly | Study Chair |
| Maria Ntalouka, MD | University Hospital of Larissa | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Univeristy of Thessaly | Larissa | Thessaly | 41110 | Greece |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided